2XBY | Blood Clotting | date | Apr 15, 2010 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic Aci Inhibitor | ||||||||||||||
authors | D.W.Banner, J.Benz, D.Schlatter, S.Thomi, W.Haap | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Activated Factor Xa Heavy Chain Chain: A Fragment: Heavy Chain, Residues 235-475 Ec: 3.4.21.6 Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Expression_system: Escherichia Coli Expression_system_taxid: 562 | ||||||||||||||
Molecule: Factor X Light Chain Chain: L Fragment: Light Chain, Residues 126-180 Ec: 3.4.21.6 Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Expression_system: Escherichia Coli Expression_system_taxid: 562 | ||||||||||||||
symmetry | Space Group: P 43 21 2 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.02 Å | ||||||||||||
ligand | 63C, CA, NA | enzyme | Hydrolase E.C.3.4.21.6 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Discovery of a factor Xa inhibitor (3R,4R)-1-(2,2-difluoro-ethyl)-pyrrolidine-3,4-dicarboxylic acid 3-[(5-chloro-pyridin-2-yl)-amide] 4-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide} as a clinical candidate., Anselm L, Banner DW, Benz J, Groebke Zbinden K, Himber J, Hilpert H, Huber W, Kuhn B, Mary JL, Otteneder MB, Panday N, Ricklin F, Stahl M, Thomi S, Haap W, Bioorg Med Chem Lett. 2010 Jul 1. PMID:20650636 |
Data retrieval |
View 2XBY in 3D |
Visual 3D analysis of 2XBY |
Structure-derived information |
Sequence-derived information |
Other resources with information on 2XBY |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |